PTGX
Protagonist Therapeutics, Inc ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
Protagonist Therapeutics, Inc (PTGX) is held by 6 tracked hedge fund(s). Largest tracked holder: RTW INVESTMENTS, LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP RTW INVESTMENTS, LP |
5.3% | 5.1M | $533M | — | $25.55 | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC VANGUARD PORTFOLIO MANAGEMENT LLC |
1.3% | 3.5M | $367M | NEW (+3.5M) | $105.40 | 2026-03-31 |
| Hood River Capital Management LLC Hood River Capital Management LLC |
0.9% | 829K | $87M | NEW (+829K) | $105.40 | 2026-03-31 |
| Driehaus Capital Management LLC Driehaus Capital Management LLC |
0.6% | 721K | $76M | ▼ 34% (−378K) | $53.14 | 2026-03-31 |
| Rubric Capital Management LP Rubric Capital Management LP |
0.5% | 428K | $45M | NEW (+428K) | $70.01 | 2026-03-31 |
| Duquesne Family Office Stanley Druckenmiller |
0.5% | 160K | $17M | — | $66.43 | 2026-03-31 |
Related ▾
FAQ ▾
Which hedge funds hold PTGX?
Tracked holders include: RTW INVESTMENTS, LP, VANGUARD PORTFOLIO MANAGEMENT LLC, Hood River Capital Management LLC, Driehaus Capital Management LLC.
How much smart money owns PTGX?
6 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading PTGX?
No tracked Congressional trades in PTGX on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.